Antonio Garrido Montalban

6 Patents

• US123781982025

  Crystalline L-arginine Salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic Acid(compound1) for Use in SIPI Receptor-associated Disorders

  Arena Pharmaceuticals, Inc.

  0 cites
• US121092192024

  Cannabinoid Receptor Modulators

  Arena Pharmaceuticals, Inc.

  0 cites
• US118846262024

  Crystalline L-arginine Salt of ( R )-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic Acid(compound1) for Use in S1P 1 Receptor-associated Disorders

  Arena Pharmaceuticals, Inc.

  0 cites
• US117716952023

  Cannabinoid Receptor Modulators

  Arena Pharmaceuticals, Inc.

  0 cites
• US116741632023

  Processes for the Preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic Acid and Salts Thereof

  Arena Pharmaceuticals, Inc.

  0 cites
• US115603692023

  Crystalline Forms and Processes for the Preparation of Cannabinoid Receptor Modulators

  Arena Pharmaceuticals, Inc.

  0 cites